Showing results (121-130 of 588) with videos related to
Sort By:
Pageof 59
Seminars in Oncology|August 12, 2009
Gastrointestinal stromal tumors I: pathology, pathobiology, primary therapy, and surgical issuesPeter Reichardt, Pancras C W Hogendoorn, Elena Tamborini, et al.Scientific Data|November 25, 2023
Plasma metabolomics profiling of 580 patients from an Early Detection Research Network prostate cancer cohortElisa Benedetti, Kelsey Chetnik, Thomas Flynn, et al.Radiology|July 21, 2007
Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in miceAntoine Hakimé, Andrew Hines-Peralta, Himaja Peddi, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 18, 2011
Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal modelWei Yang, Muneeb Ahmed, Beenish Tasawwar, et al.Radiology|April 29, 2005
Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animalsMuneeb Ahmed, Zhengjun Liu, Anatoly N Lukyanov, et al.Oncotarget|May 5, 2016
Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse modelEloah Rabello Suarez, De Kuan Chang, Jiusong Sun, et al.European Journal of Cancer (Oxford, England : 1990)|February 26, 2014
Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2αNils Kroeger, David B Seligson, Sabina Signoretti, et al.Oral Oncology|June 3, 2004
Fatty acid synthase is required for the proliferation of human oral squamous carcinoma cellsMichelle Agostini, Sabrina D Silva, Karina G Zecchin, et al.Oncotarget|March 22, 2018
Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancerSalpie Nowinski, Aida Santaolalla, Ben O'Leary, et al.Proceedings of the National Academy of Sciences of the United States of America|November 6, 2007
Identification of prostate cancer modifier pathways using parental strain expression mappingQing Xu, Pradip K Majumder, Kenneth Ross, et al.Pageof 59